“A link to a document, video, webpage.. somethin
Post# of 148161
Again, OSINT (open source) is widely available to you as an investor to comb through for information. I’ll help you this one time, but in the future, there’s a charge for my services, which were mentally and physically expensive to gain.
“Where others saw risk, however, Pourhassan saw opportunity to advance a molecule that was closer to commercialization than CytoDyn’s own cytoline. He convinced his board to take that risk. With some notable dissent, and with the stipulation that he assume the role of CEO, he proceeded to raise $7 million from private backers in fewer than thirty days. On October 10, 2012, he wired three and a half million dollars to Progenics to acquire PRO 140. “Then,” he tells me, “I gave the remaining $6 million Progenics had been awarded back to the NIH.”
https://www.bioprocessonline.com/doc/the-peri...uster-0001